Tech Company Financing Transactions
Atossa Genetics Funding Round
Atossa Genetics closed a $6.6 million financing round on 6/27/2011. Backers included private investors.
Transaction Overview
Company Name
Announced On
6/27/2011
Transaction Type
Venture Equity
Amount
$6,600,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds from the offering will be used to produce the MACST System in commercial quantities; establish a cytology and molecular diagnostics laboratory focused on breast health; launch the Mammary Aspirate Specimen Cytology Test System (MASCT System) in the Northwestern United States, including hiring and training sales personnel; continue development of the second generation MASCT System; and develop additional products and services.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
107 Spring St.
Seattle, WA 98104
USA
Seattle, WA 98104
USA
Phone
Website
Email Address
Not Recorded
Overview
Atossa Genetics is a healthcare company developing cellular and molecular diagnostic risk assessment products for breast cancer patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Quay
Chief Financial Officer
Kyle Guse
VP - Regulatory Affairs
Janet Rea
Browse more venture capital transactions:
Prev: 6/27/2011: MacroSolve venture capital transaction
Next: 6/27/2011: ScrollMotion venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs